The biotech startup Inscripta is attempting to “democratize” CRISPR by offering it to select researchers at no cost, according to Fortune. Here are four things to know about the startup’s business ...
Despite a challenging CASGEVY launch, high cash burn, and an almost 10% YTD share count growth, CRISPR’s pipeline breadth and ...
Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.
The pre-Series A funding round was led by Spectrum Impact with participation from the founders and existing investors including Vijay Alreja Family Office.
CRISPR, the gene-editing technology which won its creators the 2020 Nobel Prize for Chemistry, is most well-known for its ...
7don MSN
Teens may have come up with a new way to detect, treat Lyme disease using CRISPR gene editing
To compete at iGEM, a sort of science Olympics, teens at a Georgia high school set their sights on finding a better way to ...
DURHAM – A Durham startup pioneering the use of gene editing technology known as CRISPR is shipping its first products to market in what also is a first for the emerging CRISPR industry. Pairwise ...
CrisprBits has secured $3 Mn (INR 26.8 Cr) in a pre-Series A funding round led by Spectrum Impact and Rajendra Gogri's family ...
Aera Therapeutics, a startup launched by the CRISPR pioneer Feng Zhang last year to solve one of the biggest bottlenecks in genetic medicine, has laid off a quarter of its staff, the company confirmed ...
Verve Therapeutics, a Cambridge, Mass.-based startup that plans to use gene editing technology to treat heart disease, announced its official launch and $58.5 million in Series A financing on May 7.
Oct 7, 2020, 10:38am EDT Updated: Oct 7, 2020, 11:06am EDT Spencer A. Brown FILE — CRISPR gene-editing technology inventor Jennifer Doudna of the University of California, Berkeley, accepts the Life ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results